SNX-482

Gly-Val-Asp-Lys-Ala-Gly-Cys-Arg-Tyr-Met-Phe-Gly-Gly-Cys-Ser-Val-Asn-Asp-Asp-Cys-Cys-Pro-Arg-Leu-Gly-Cys-His-Ser-Leu-Phe-Ser-Tyr-Cys-Ala-Trp-Asp-Leu-Thr-Phe-Ser-Asp (Disulfide bonds between Cys⁷-Cys²¹, Cys¹⁴-Cys²⁶, and Cys²⁰-Cys³³)
: (M.W. 4495.0) C₁₉₂H₂₇₄N₅₂O₆₀S₇
: Class E (R-type) Ca²⁺ Channel Blocker

Package	Price(Yen)	Availability	Quantity
Vial 0.1 mg	30,000	Ships within 1-3 business days
バルク見積もり

Solubility: 0.02% NH₄OH (0.1 mM)

R. Newcomb, B. Szoke, A. Palma, G. Wang, X.-h. Chen, W. Hopkins, R. Cong, J. Miller, L. Urge, K. Tarczy-Hornoch, J.A. Loo, D.J. Dooley, L. Nadasdi, R. W. Tsien, J. Lemos, and G. Miljanich, Biochemistry, 37, 15353 (1998). (Original)
L. Ürge, B. Szöke, D. Silva, P. Tran-Tau, D. Hom, K. Tarczy-Hornoch, and L. Nádasdi, Peptides 1998, (S. Bajusz and F. Hudecz, eds.), pp.748-749 (1999). (S-S Bond)
A. Tottene, S. Volsen, and D. Pietrobon, J. Neurosci., 20, 171 (2000). (Pharmacol.)
G. Wang, G. Dayanithi, R. Newcomb, and J. R. Lemos, J. Neurosci., 19, 9235 (1999). (Pharmacol.)
D. Sochivko, A. Pereverzev, N. Smyth, C. Gissel, T. Schneider, and H. Beck, J. Physiol., 542, 699 (2002). (Pharmacol.)
X. Jing, D.-Q. Li, C.S. Olofsson, A. Salehi, V.V. Surve, J. Caballero, R. Ivarsson, I. Lundquist, A. Pereverzev, T. Schneider, P. Rorsman, and E. Renström, J. Clin. Invest., 115, 146 (2005). (Pharmacol.)